Cerebrovascular Complications of l-Asparaginase in the Therapy of Acute Lymphoblastic Leukemia
Authors:
- Matthias KieslichMKMatthias Kieslich
- Luciana PortoLPLuciana Porto
- Heinrich LanfermannHLHeinrich Lanfermann
- Gert JacobiGJGert Jacobi
- Dirk SchwabeDSDirk Schwabe
- Hansjosef BöhlesHBHansjosef Böhles
- 1 June 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 25 (6) , 484-487
Abstract
L-asparaginase is frequently used in combination therapy for the treatment of lymphoid malignancies. We report 5 children aged between 8 and 14 years with neurologic complications presenting with headache and seizures during the first three weeks of l-asparaginase treatment. Three patients had venous thrombosis, one presented a parenchymal hemorrhage, and one showed a peculiar encephalopathy with extended cortical and subcortical lesions suggesting a neurotoxic reaction. Decreased fibrinogen and antithrombin III levels were found. Early MRI is critical even in cases with mild neurologic symptoms. Diagnosis should be followed by early cessation of l-asparaginase application.Keywords
This publication has 13 references indexed in Scilit:
- Thrombotic events are not exclusive to the remission induction period in patients with acute lymphoblastic leukemia: a report of two cases of cerebral sinus thrombosisAnnals of Hematology, 1997
- Transient hyperlipidemia during treatment of ALL with L-asparaginase is related to decreased lipoprotein lipase activityLeukemia, 1997
- Effects of Erwinia‐asparaginase on the coagulation systemEuropean Journal of Haematology, 1995
- Enhanced thrombin generation, P-von willebrand factor, P-fibrin D-dimer and P-plasminogen activator inhibitor 1: Predictive for venous thrombosis in asparaginase-treated childrenFibrinolysis, 1994
- Bildgebende Verfahren in der Diagnostik zerebrovaskulärer Komplikationen unter L-Asparaginase-TherapieKlinische Padiatrie, 1994
- Increased endogenous thrombin generation in children with acute lymphoblastic leukemia: risk of thrombotic complications in L'Asparaginase-induced antithrombin III deficiencyBlood, 1994
- Pharmacokinetics of PEG-l-asparaginase and plasma and cerebrospinal fluidl-asparagine concentrations in the rhesus monkeyCancer Chemotherapy and Pharmacology, 1993
- Gerinnungsveränderungen bei Behandlung mit den Protokollen ALL-BFM-90 und NHL-BFM-90Klinische Padiatrie, 1992
- The effect of L-asparaginase on lipid metabolism during induction chemotherapy of childhood lymphoblastic leukaemiaEuropean Journal of Pediatrics, 1988
- Cerebrovascular complications of L‐asparaginase therapyNeurology, 1988